Fairvoy Private Wealth’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229K Buy
2,266
+2
+0.1% +$207 0.05% 191
2026
Q1
$219K Sell
2,264
-2
-0.1% -$205 0.05% 192
2025
Q4
$241K Buy
2,266
+1
+0% +$116 0.05% 172
2025
Q3
$288K Sell
2,265
-73
-3% -$8.69K 0.07% 157
2025
Q2
$287K Buy
2,338
+81
+4% +$9.25K 0.07% 151
2025
Q1
$229K Buy
2,257
+2
+0.1% +$195 0.06% 161
2024
Q4
$208K Buy
+2,255
New +$221K 0.06% 169

Other funds holding EHC

Fairvoy Private Wealth's EHC Position: Q2 2026 in Review

Fairvoy Private Wealth increased its Encompass Health (EHC) stake by 0.09% in Q2 2026, buying an estimated $207 and bringing the position to 2,266 shares worth $229K. The position accounts for 0.05% of the portfolio, ranked #191.

Fairvoy Private Wealth first reported a position in EHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $288K in Q3 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Fairvoy Private Wealth held 2,266 shares of Encompass Health worth $229K as of Q2 2026.
  • Fairvoy Private Wealth bought 2 Encompass Health shares in Q2 2026, an estimated $207.
  • Encompass Health made up 0.05% of Fairvoy Private Wealth's portfolio in Q2 2026, its #191 holding.
  • Fairvoy Private Wealth first reported a position in Encompass Health in Q4 2024 and has held it in 7 quarters since.
  • Fairvoy Private Wealth's Encompass Health position peaked at $288K in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Fairvoy Private Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.